Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Search
Thursday, February 13, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Demand Local Launches LinkOne: The Automotive Industry’s Most Cost-Effective 1st Party…
New York Blood Center Enterprises Researchers Identify New Immune Response Mechanisms…
Siemens to accelerate customer time to market with advanced silicon IP…
RTX’s Raytheon Conducts Successful Test with LTAMDS and PAC-2 GEM-T Missile
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Resource Center
Resources
Press Releases
Home
Tags
ESSA Pharma
ESSA Pharma
Biotechnology
ESSA Pharma Begins Clinical Trial of EPI-7386 in Combination with Enzalutamide For Prostate Cancer
PR Newswire
-
January 20, 2022
ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the first patient dosed in...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Demand Local Launches LinkOne: The Automotive Industry’s Most Cost-Effective 1st Party Customer Data Portal
New York Blood Center Enterprises Researchers Identify New Immune Response Mechanisms in Sickle Cell Disease
Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
Load more
